|
Oct 9
|
Bioventus Inc (BVS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
|
|
Oct 1
|
Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
|
|
Sep 27
|
ABBV's Newly Added Parkinson's Disease Drug Meets Second Study Goal
|
|
Aug 30
|
JNJ Seeks First FDA Nod for Autoimmune Disease Drug Nipocalimab
|
|
Aug 30
|
Merck Scraps Two Late-Stage Keytruda Studies on Disappointing Data
|
|
Aug 29
|
Bull Of The Day: Bioventus (BVS)
|
|
Aug 29
|
Bioventus and Pool have been highlighted as Zacks Bull and Bear of the Day
|
|
Aug 28
|
Pfizer Follows Lilly's Example, Unveils DTC Service for Selling Drugs
|
|
Aug 28
|
Soleno Stock Up as FDA Accepts PWS Drug NDA Under Priority Review
|
|
Aug 27
|
Insmed Stock Surges 168% in the Past Six Months: Here's Why
|
|
Aug 26
|
AstraZeneca (AZN) Denies Rumors About UK Facility Relocation
|
|
Aug 7
|
Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
|
|
Aug 6
|
Bioventus Reports Second Quarter Financial Results
|
|
Jul 30
|
Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
|
|
Jun 5
|
Here's Why You Should Consider Buying Bioventus (BVS) Stock
|
|
Jun 5
|
J&J (JNJ) Seeks Expanded Use of HIV Drug in US and Europe
|
|
May 31
|
Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody
|
|
May 30
|
Merck (MRK) to Buy Private Ophthalmology Company EyeBio
|
|
May 8
|
Bioventus Inc. (NASDAQ:BVS) Q1 2024 Earnings Call Transcript
|
|
May 8
|
Bioventus Inc (BVS) Q1 2024 Earnings Call Transcript Highlights: Strong Start with Significant ...
|